Cargando…
Could NICE guidance on the choice of blood pressure lowering drugs be simplified?
Reecha Sofat and colleagues argue that prescribing advice needs updating in the light of recent evidence that all classes of blood pressure lowering drugs are broadly equivalent
Autores principales: | Sofat, Reecha, Casas, Juan P, Grosso, Anthony M, Prichard, Brian N C, Smeeth, Liam, MacAllister, Raymond, Hingorani, Aroon D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957318/ https://www.ncbi.nlm.nih.gov/pubmed/22246267 http://dx.doi.org/10.1136/bmj.d8078 |
Ejemplares similares
-
Oral Bisphosphonates and Risk of Atrial Fibrillation and Flutter in Women: A Self-Controlled Case-Series Safety Analysis
por: Grosso, Anthony, et al.
Publicado: (2009) -
Translating genomics into improved healthcare
por: Hingorani, Aroon D, et al.
Publicado: (2010) -
Improving the odds of drug development success through human genomics: modelling study
por: Hingorani, Aroon D., et al.
Publicado: (2019) -
Association of Smoking, Alcohol Consumption, Blood Pressure, Body Mass Index, and Glycemic Risk Factors With Age-Related Macular Degeneration: A Mendelian Randomization Study
por: Kuan, Valerie, et al.
Publicado: (2021) -
Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study
por: Herrett, Emily, et al.
Publicado: (2019)